The Pfizer study used conventional response criteria .
An early interim analysis found no survival advantage for the treated patients , leading to the termination of the trial in April 2008 .
The Pfizer study used conventional response criteria , and an early interim analysis found no survival advantage for the treated patients , leading to the termination of the trial in April 2008 .